SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001279569-23-001406
Filing Date
2023-11-06
Accepted
2023-11-06 13:56:33
Documents
12
Period of Report
2023-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 28514
  Complete submission text file 0001279569-23-001406.txt   198464

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20231006.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20231006_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20231006_pre.xml EX-101.PRE 22372
6 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3165
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

IRS No.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 231379392
SIC: 2833 Medicinal Chemicals & Botanical Products